TODD NEWMAN: Open Payments
NPI 1730398140 · HOBOKEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$33,073 in 343 payments from 24 companies in 2025. Trend: 2023 $13,691 · 2024 $17,859 · 2025 $33,073
Speaker / faculty: $21,660Food & beverage: $6,466Consulting: $2,743Travel & lodging: $2,106Education: $99
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 37 | $11,979 |
| Regeneron Healthcare Solutions, Inc. | 32 | $7,930 |
| GENZYME CORPORATION | 20 | $5,758 |
| Incyte Corporation | 36 | $3,456 |
| LEO Pharma Inc. | 26 | $524 |
| ABBVIE INC. | 28 | $521 |
| Novartis Pharmaceuticals Corporation | 25 | $486 |
| Janssen Biotech, Inc. | 16 | $444 |
| Arcutis Biotherapeutics, Inc. | 24 | $358 |
| PFIZER INC. | 18 | $259 |
Products named: DUPIXENT, NEMLUVIO, OPZELURA, TREMFYA, ADBRY, Zoryve, SKYRIZI, RINVOQ.
Industry payments across NJ — which companies pay providers there.
